StockData
BriaCell Therapeutics Corp. logo

BriaCell Therapeutics Corp. (BCTX) income statement

BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ
Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 28, 2026Score 4/30
$3.16−0.12 (-3.66%)

Close on Nov 19, 2026Market cap $27.59MP/E –Yield –

See a number that looks wrong?